Sunday, September 28, 2014

Ebola-related shares

Companies that are part of the growing effort to find an effective treatment for the deadly Ebola virus:

Pharmaceuticals
  • Ibio (IBIO) - may become part of the government's effort to ramp up production of ZMapp. The experimental drug was developed by privately-held Mapp Biophamaceuticals and used to save the lives of two American health workers who were infected but recovered. 
  • Tekmira Pharmaceuticals (TKMR) -  maker of the TKM-Ebola drug
  • Mapp Biopharmaceutical (private): Mapp’s therapy for Ebola, known as ZMapp, is getting a lot of attention for its ability to treat the disease, even if the company is getting no mileage in the stock market. ZMapp has been was used to treat two U.S. health workers who were infected but recovered. Three Liberians were treated with ZMapp, one of whom died. An elderly Spanish priest died after using the drug, but a British nurse working in Sierra Leone recovered after receiving ZMapp.
Others
  • Lakeland Industries (LAKE) - hazmat-suit maker
  • Alpha Pro Tech (APT) -  face mask maker

  

No comments:

Post a Comment